| Bioactivity | Resomelagon methanesulfonate (AP1189 methanesulfonate) is the methanesulfonate salt form of Resomelagon (HY-147301). Resomelagon methanesulfonate is an orally active melanocortin receptor (MR) agonist. Resomelagon methanesulfonate induces ERK1/2 phosphorylation and Ca2+ mobilization. Resomelagon methanesulfonate exhibits anti-inflammatory activity in mouse peritonitis and peritonitis model. Resomelagon methanesulfonate can be used for obesity and chronic inflammation research[1][2]. |
| CAS | 2933183-20-9 |
| Formula | C15H18N6O5S |
| Molar Mass | 394.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Montero-Melendez T, et, al. Biased agonism as a novel strategy to harness the proresolving properties of melanocortin receptors without eliciting melanogenic effects. J Immunol. 2015 Apr 1;194(7):3381-8. [2]. WHO Drug Information. International Nonproprietary Names for Pharmaceutical. |
Resomelagon methanesulfonate
CAS: 2933183-20-9 F: C15H18N6O5S W: 394.41
Resomelagon methanesulfonate (AP1189 methanesulfonate) is the methanesulfonate salt form of Resomelagon (HY-147301). Res
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.